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Abstract 
Background: Patients with low ejection fraction (EF) are at a higher risk for 
postoperative complications and mortality. Our objective was to assess the effect of low 
EF (<40%) on early clinical outcomes after coronary artery bypass grafting (CABG) and 
to determine the predictors of mortality.
Methods: From June 2017 to February 2019, 170 consecutive patients underwent 
CABG. There were 120 patients with low EF (<40%; 37.49 ± 2.89%); 94 were men 
(78.3%), and the mean age was 55.83 ± 8.04 years. Fifty patients had normal EF (> 40; 
57.90 ± 2.27 %), 41 were men (82.0%), and the mean age was 54.30 ± 7.01 years and 
used as a control group. 
Results: Overall 30-day mortality was 10/120 patients (8.3%). Factors associated with 
higher mortality were females ( 70.0% vs. 17.3%, P<0.001); older age (61.40 ± 7.01 vs. 
55.32 ± 7.97 years, P=0.025); diabetes mellitus (100% vs. 51.8%; P=0.003); longer 
cardiopulmonary bypass time (148.70 ± 40.12 vs. 108.49 ± 36.89 min; P=0.012); longer 
cross clamp time  (88.19 ± 31.94 vs.64.77 ± 22.67 min; P=0.049), longer total operative 
time (6.82 ± 1.03 vs 5.38 ± 0.95 hours; P=0.001); intra-aortic balloon pump (IABP) 
insertion (90.0% vs. 10.9%; P<0.001); intra-operative complications (60% vs. 1.8%, 
P<0.001); ventricular tachycardia and ventricular fibrillation (30% and 50% vs. 4.5% and 
5.5% respectively; P=0.002 for both); myocardial infarction (70% vs 11.8%, P<0.001), 
and lower postoperative ejection fraction (21.46 ± 1.93 vs 40.30 ± 8.19 %,  P<0.001). In 
patients with low EF, postoperative NYHA and CCS angina class have improved 
compared to the preoperative levels (1.50 ± 0.61 vs. 3.31 ± 0.56; p< 0.001 and 1.38 ± 
0.52 vs. 3.11 ± 0.55; p< 0.001 respectively)
Conclusion: Patients with low EF have a higher risk of morbidity and mortality; however, 
the clinical and echocardiographic parameters improve over time. Therefore, CABG 
remains a viable option in selected patients with low EF. Factors affecting our 30-days 
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Introduction 
Ischemic heart disease is one of the major 
causes of death, disability and healthcare resource 
utilization worldwide. Recent advances in 
operative techniques and perioperative care 
resulted in an increased number of elderly 
patients undergoing coronary artery bypass 
grafting (CABG) with significant improvement in 
the quality of life [1]. Cardiovascular disease 
remains the leading cause of mortality worldwide, 
accounting for 40% of the total number of deaths, 
with 20% related to coronary artery disease. 
Cardiovascular disease causes the premature 
death of 1.5 million people per year [2].  
Coronary artery bypass grafting effectively 
relieves angina and improves survival [3], In 
patients with coronary artery disease and low EF, 
the effect of CABG on improving the left 
ventricular function and the quality of life are the 
subjects of ongoing research [4,5]. These patients 
are at higher risk of postoperative complications; 
however, improved long-term outcomes were 
reported [6]. The current study aimed to assess 
the early effect of low EF (<40%) on clinical 
outcomes after coronary artery bypass grafting 
and to determine the predictors of mortality.  
Patients and Methods: 
Study setting: 
This is a prospective cohort study performed 
between June 2017 and February 2019 on 170 
patients with ischemic heart disease who had 
elective CABG at the National Heart Institute and 
Ain Shams University Hospital. We exclude 
Patients who needed concomitant cardiac surgery 
with coronary artery bypass grafting surgery, redo 
cardiac surgery, very low EF (<20%) and 
emergency patients. 
All patients had a complete history taken, 
followed by comprehensive physical and local 
cardiac examinations. Pre-operative Dobutamine 
stress echocardiography was done for all patients 
with low EF (<40%) and revealed significant 
improvement in EF. The study was approved by 
the Ethical Committee of the participating 
institutions, and all patients provided written 
informed consents for the use of their de-
identified data for research purposes. Patients 
demographics are summarized in Table 1. 
Operative techniques: 
A standard median sternotomy was used in all 
patients. Left Internal Mammary artery (LIMA) and 
saphenous vein grafts were harvested. 
Cardiopulmonary bypass (CPB) was established via 
cannulation of the ascending aorta, and the right 
atrium was cannulated via single venous cannula. 
The distal anastomoses were done at first then all 
proximal anastomoses were done after removal of 
aortic cross-clamp. Surgery was performed under 
normothermia. Myocardial protection was 
achieved with an intermittent warm blood 
cardioplegia after every graft anastomosis or 
every 20 minutes according to surgeon 
preference.  
The indications for IABP were: a) failure of 
weaning from CPB despite maximum inotropic 
support, b) patients with low cardiac output after 
a "difficult" weaning from CPB, supported by high-
doses of inotropes, c) patients with "difficult" 
weaning from CPB and arrhythmia (premature 
ventricular beats or ventricular tachycardia (VT) d) 
post-cardiotomy low cardiac output syndrome. 
The IABP was inserted percutaneously through the 
common femoral artery. 
After surgery, patients were transferred to 
the ICU. Weaning from mechanical ventilation was 
started, in the absence of hemodynamic instability 
and significant bleeding, as soon as normothermia 
and an adequate level of consciousness were 
achieved. Conventional therapy included 
antibiotics, hydration, antacids, and diuretics, as 
well as inotropic drugs and mechanical circulatory 
support devices when required by the 
hemodynamic conditions. Myocardial infarction 
was defined according to the Consensus 
Conference for the Universal Definition of 
Myocardial Infarction [7]. Low cardiac output 
syndrome was defined as arterial hypotension 
(systolic blood pressure <100 mmHg) with signs of 
organ hypoperfusion (decreased urine output, 
lactic acidosis) and the cardiac index below 2 
l/min/m2 despite adequate fluid replacement. 
We followed all patients clinically and 
echocardiography at the outpatient clinic or 
contacted by phone periodically one and three 
months postoperatively.
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Table 1: Patients’ demographics. Values are presented as numbers (%) or mean + SD. * indicate 
significant difference between the groups (p<0.05) 
Low EF group Control group 
P value 
(n=120) (n=50) 
Female 26 (21.6%) 9 (18.0%) 0.286 
Age (years) 55.83 ± 8.04 54.30 ± 7.01 0.242 
BMI (Kg/m2) 29.89 ± 4.55 29.27 ± 4.35 0.413 
Smoking 57 (47.5%) 26 (52.0%) 0.592 
Dyslipidemia 58 (48.3%) 23 (46.0%) 0.781 
Hypertension 65 (54.1%) 22 (44.0%) 0.226 
Diabetics 67 (55.8%) 21 (42.0%) 0.100 
Preoperative LVEDD (cm) 5.79 ± 0.53 5.44 ± 0.56 < 0.001* 
Preoperative LVESD (cm) 4.58 ± 0.70 3.53 ± 0.60 < 0.001* 
Preoperative EF (%) 37.49 ± 2.89 57.90 ± 2.27 < 0.001* 
Preoperative NYHA class 
II 6 (5.0%) 6 (12.0%) 
0.113 III 70 (58.3%) 32 (64.0%) 
IV 44 (36.7%) 12 (24.0%) 
Preoperative CCS grade 
II 12 (10.0%) 9 (18.0%) 
0.165 III 82 (68.3%) 35 (70.0%) 
IV 26 (21.7%) 6 (12.0%) 
Number of diseased vessels 
Single 3 (2.5%) 3 (6.0%) 
0.193 
2-vessels 11 (9.1%) 8 (16.0%) 
3-vessels 38 (31.6%) 17 (34.0%) 
4-vessels 51 (42.5%) 20 (40.0%) 
5-vessels 17(14.1%) 2 (4.0%) 
BMI= body mass index, EF= ejection fraction, LVEDD = left ventricular end diastolic 
diameter, LVESD= left ventricular end systolic diameter, NYHA= New York Heart 
Association, CCS= Canadian cardiovascular society. 
Statistical analysis 
Data were collected, revised, coded and 
entered the Statistical Package for Social Science 
(IBM SPSS) version 20 (IBM Corporation, Chicago, 
IL, USA). Qualitative data were presented as 
number and percentages while quantitative data 
with parametric distribution were presented as 
mean, standard deviations and ranges. The 
comparison between two groups with qualitative 
data was done by using the Chi-squared test or 
Fisher exact test when the expected count in any 
cell was found less than 5. Comparison between 
two independent groups regarding quantitative 
data with parametric distribution was done by 
using the independent t-test. Paired t-test was 
used to compare pre and postoperative changes in 
the low EF group.  Comparison between more 
than two independent groups regarding 
quantitative data with parametric distribution was 
made by using One Way ANOVA. 
Results 
Preoperatively; dobutamine stress echo-
cardiography was done for all patients. The EF at 
rest was 37.63 ± 2.66 % and improved to 46.98 ± 
3.29 % after the test. There was total viable 
myocardium in 94 patients (78.33%), partial non-
viable myocardium in left anterior descending 
(LAD) artery territory in 8 patients (6.67%), partial 
or total non-viable myocardium in the right 
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Table 2: Operative and postoperative outcomes. Values are presented as numbers (%) or mean + SD. * indicate 
significant difference between the groups (p<0.05) 
Low EF group Control group P value 
(n= 120) (n= 50) 
Number of grafts 3.12 ± 1.00 2.68 ± 0.89 0.007* 
Type of grafts 
LIMA 116 (96.6%) 48 (96.0%) 0.830 
RIMA 7 (5.8%) 2 (4.0%) 0.626 
Radial 6 (5%) 7 (14.0%) 0.044* 
SV 117 (97.5%) 47 (94.0%) 0.259 
CBP time (min) 111.95 ± 41.27 103.40 ± 54.98 0.267 
ACC time (min) 66.72 ± 24.90 62.54 ± 40.82 0.415 
Total operative time (hours) 5.53 ± 0.81 5.12 ± 1.03 0.006* 
DC Shock application 49 (40.8%) 16 (32.0%) 0.280 
Surgical technique problems 9 (7.5%) 2 (4.0%) 0.398 
Intra-operative complications 8 (6.6%) 2 (4.0%) 0.500 
Re exploration  7 (5.8%) 3 (6.0%) 0.964 
Mediastinal drainage (ml) 749.35 ± 377.99 694.34 ± 390.94 0.393 
Duration of Mechanical ventilation (hrs) 17.99 ± 24.58 16.98 ± 26.16 0.811 
ICU stay (days) 3.75 ± 1.93 3.39 ± 1.69 0.252 
Total hospital stays (days) 8.85 ± 3.33 7.93 ± 4.10 0.127 
Postoperative cardiac 
support 
Adrenaline 93 (77.5%) 26 (52.0%) < 0.001* 
Dobutamine  6 (5.0%) 1 (2.0%) 0.369 
Levosimendan 14 (11.6%) 2 (4.0%) 0.118 
IABP insertion 21 (17.5%) 3 (6.0%) 0.049* 
Superficial wound infection  11 (9.1%) 4 (8.0%) 0.806 
Cerebrovascular events 6 (5.0%) 1 (2.0%) 0.369 
MI 20 (16.6%) 5 (10.0%) 0.263 
Non-fatal MI 13 (10.8%) 4 (8.0%) 0.574 
Non-fatal cerebrovascular events 5 (4.1%) 1 (2.0%) 0.015* 
Readmission for HF 5 (4.1%) 1 (2.0%) 0.015* 
30-days mortality 10 (8.3%) 1 (2.0%) 0.126 
Post-operative NYHA 
class 
I 61 (55.4%) 29 (59.2%) 
II 42 (38.2%) 18 (36.7%) 0.813 
III 7 (6.4%) 2 (4.1%) 
Postoperative CCS 
grade 
I 70 (63.6%) 31 (63.3%) 
II 38 (34.6%) 17 (34.7%) 0.995 
III 2 (1.8%) 1 (2.0%) 
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Table 2: Continued 
Postoperative LVEDD (cm) 5.67 ± 0.49 5.40 ± 0.54 0.007* 
Postoperative LVESD (cm) 4.43 ± 0.68 3.44 ± 0.57 0.002* 
Postoperative EF (cm) 38.98 ± 8.50 59.44 ± 6.88 < 0.001* 
30-days mortality 10 (8.3%) 1 (2.0%) 0.126 
LIMA= left internal mammary artery, RIMA= right internal mammary artery, SV= Saphenous vein, CPB= 
cardiopulmonary bypass, ACC= aortic cross-clamp, DC= defibrillating cardiac, ICU= intensive care unit, 
IABP= intra-aortic balloon pump, MI= Myocardial infection, HF= Heart failure, NYHA= New York Heart 
Association, CCS= Canadian cardiovascular society, EF= ejection fraction, LVEDD = left ventricular end 
diastolic diameter, LVESD= left ventricular end systolic diameter. 
coronary artery (RCA) territory in 12 patients 
(10.0%) and partial or total non-viable 
myocardium in circumflex (LCX) artery territory in 
6 patients (5.0%). 
Table 2 shows the study outcomes.  Nine 
patients (7.5 %) had surgical technique problems; 
4 of them had dissected LIMA which was used as a 
free graft in one patient. In 2 patients, LAD could 
not be determined, and there was kinking of vein 
grafts to OM in one patient and the one patient 
required re-anastomosis of LIMA to LAD. 
There were highly significant improvements in 
NYHA classification, CCS grade and ejection 
fraction postoperatively in comparison to the 
preoperative value as shown in Table 3. 
Cerebrovascular events occurred in 6 patients 
(5.0%). A patient had deep coma, and brain stem 
massive bilateral infarction and the patient died 
the second day postoperatively. The second 
patient had right side hemiparesis, and left 
parietal infarction; preoperative carotid duplex 
was not indicated. The third patient had right side 
hemiparesis and ataxia, caused by left parietal and 
cerebellar infarction; preoperative carotid duplex 
showed bilateral atherosclerotic arteries with left 
side carotid lesion 50%. The fourth patient had 
Left side hemiparesis, and right parieto-occipital 
infarction; preoperative carotid duplex showed 
bilateral atherosclerotic arteries without 
significant lesion. The fifth patient had right side 
hemiparesis and left focal infarction in parietal 
and temporal lobes; preoperative carotid duplex 
revealed left side carotid lesion 65%. The last 
patient had left lower limb hemiparesis, and CT 
brain revealed right parietal infarction, 
preoperative carotid duplex revealed 
atherosclerotic carotid on both sides without 
significant lesions. 
The 30-days mortality occurred in ten cases; 
two patients were due to failure of weaning from 
CPB and seven patients died due to myocardial 
infarction (one intraoperatively, four before 
discharge and two patients were readmitted to 
CCU). The last patient died from a non-cardiac 
cause.  
Table 3: Preoperative and postoperative outcomes comparison in low EF group. Values are presented as numbers (%) 
or mean + SD. * indicate significant difference between the groups (p<0.05) 
Preoperative Postoperative P value 
(n=120) (n= 110) 
NYHA class 3.31 ± 0.56 1.50 ± 0.61 < 0.001* 
CCS grade 3.11 ± 0.55 1.38 ± 0.52 < 0.001* 
LVEDD (cm) 5.79 ± 0.53 5.63 ± 0.51 0.002* 
LVESD (cm) 4.58 ± 0.70 4.35 ± 0.64 0.001* 
EF (%) 37.49 ± 2.89 40.30 ± 8.19 < 0.001* 
NYHA= New York Heart Association, CCS= Canadian cardiovascular society, EF= ejection 
fraction, LVEDD = left ventricular end diastolic diameter, LVESD= left ventricular end systolic 
diameter.
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Table 4: Factors affecting 30 days mortality. Values are presented as numbers (%) or mean + SD. * indicate significant 
difference between the groups (p<0.05) 
Survival (N= 110) 
group
Mortality (N= 10) 
group
P value 
Female 19 (17.3%) 7 (70.0%) < 0.001* 
Age (Years) 55.32 ± 7.97 61.40 ± 7.01 0.025* 
BMI (Kg/m2) 29.74 ± 4.44 32.47 ± 5.01 0.127 
Smoking 54 (49.1%) 3 (30.0%) 0.247 
Dyslipidemia 51 (46.4%) 7 (70.0%) 0.152 
Hypertension 59 (53.6%) 6 (60.0%) 0.698 
Diabetes Mellitus 57 (51.8%) 10 (100.0%) 0.003* 
Preoperative NYHA class 
II 6 (5.5%) 0 (0.0%) 
0.222 III 68 (61.8%) 2 (20.0%) 
IV 36 (32.7%) 8 (80.0%) 
Preoperative LVEDD (cm) 5.76 ± 0.53 6.07 ± 0.49 0.077 
Preoperative LVESD (cm) 4.55 ± 0.69 4.85 ± 0.82 0.197 
Preoperative EF (%) 37.60 ± 2.95 36.20 ± 2.09 0.145 
Number of grafts 3.13 ± 1.01 3.00 ± 0.67 0.691 
CBP time (min) 108.49 ± 36.89 148.70 ± 40.12 0.001* 
ACC time (min) 64.77 ± 22.67 88.19 ± 31.94 0.003* 
Total operative time (hour) 5.38 ± 0.95 6.82 ± 1.03 < 0.001* 
DC shock application (intra-operative) 44 (40.0%) 7 (70.0%) 0.066 
Intra operative complications 2 (1.8%) 6 (60.0%) < 0.001* 
Re exploration for bleeding 7 (6.3%) 0 (0.00%) 0.410 
Duration of mechanical ventilation (hour) 16.99 ± 21.67 28.75 ± 19.42 0.096 
ICU stay (days) 3.84 ± 1.93 2.84 ± 1.70 0.116 
Postoperative inotropic support 83 (75.4%) 10 (100.0%) 0.075 
IABP insertion 12 (10.9%) 9 (90.0%) < 0.001* 
Arrhythmia 
AF 51 (46.3%) 2 (20.0%) 0.107 
0.000Nodal 4 (3.6%) 0 (0.00%) .539 
V Tach 4 (4.5%) 3 (30.0%) 0.002* 
VF 6 (5.5%) 5 (50.0%) 0.002* 
Cerebrovascular events 5 (4.5%) 1 (10.0%) 0.448 
Myocardial infarction 13 (11.8%) 7 (70.0%) < 0.001* 
ICU readmission 14 (12.7%) 1 (10.0%) 0.803 
Early postoperative LVEED (cm) 5.63 ± 0.51 5.99 ± 0.44 0.033* 
Early postoperative LVESD (cm) 4.35 ± 0.64 5.31 ± 0.37 < 0.001* 
Early postoperative EF (%) 40.30 ± 8.19 21.46 ± 1.93 < 0.001* 
BMI= body mass index, EF= ejection fraction, LVEDD = left ventricular end diastolic diameter, LVESD= left 
ventricular end systolic diameter, CPB= cardiopulmonary bypass, ACC= aortic cross clamp, DC= 
defibrillating cardiac ICU= intensive care unit, IABP= intra-aortic balloon pump, NYHA= New York Heart 
Association,  EF= ejection fraction, LVEDD = left ventricular end diastolic diameter, LVESD= left 
ventricular end systolic diameter, AF= atrial fibrillation, V Tach= Ventricular tachycardia, VF= ventricular 
fibrillation.
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Table 4 shows factors significantly associated 
with 30-days mortality including female gender, 
older age, diabetes, longer cardiopulmonary 
bypass time, longer cross-clamp time, intra-aortic 
balloon pump (IABP) insertion, ventricular 
tachycardia, and ventricular fibrillation, 
myocardial infarction and lower ejection fraction 
postoperatively.  
Discussion 
Low ejection fraction can negatively affect the 
outcomes after CABG. The purpose of this study 
was to evaluate the impact of low EF on the results 
after CABG and identify the predictors of 
mortality. The primary outcome was the 30-days 
mortality which occurred in 8.3% of the patients. 
Operative mortality ranged from 3.4% to 4.4% in 
the reported series [5, 8, 9]. In our study, 
mortality was significantly associated with both 
preoperative; as well as intraoperatively risk 
factors. Preoperative predictors included female 
gender, older age, diabetes mellitus, longer 
cardiopulmonary bypass, cross-clamp time and 
operative times, IABP insertion, ventricular 
tachycardia, and ventricular fibrillation, 
myocardial infarction and lower early ejection 
fraction postoperatively. 
Several risk factors for mortality were 
identified in other series and included older age, 
female gender, renal failure, hepatic failure, and 
congestive heart failure [8]. In another series, 
early mortality was independently associated with 
age ≥75 years, female gender, angina (CSS III-IV), 
cardiopulmonary bypass duration >97 minutes, 
arrhythmia and renal impairment [10]. 
In our study, the major adverse cardiac events 
(MACE) were higher in the low EF group than the 
control group and non-fatal cerebrovascular 
events (4.1% vs. 2%), non-fatal myocardial 
infarction (10.8% vs. 8%), heart failure (4.1% vs. 
2%) and mortality rate (8.3% vs. 2%) occurred 
more significantly in low EF patients. Additionally, 
we found a significantly higher number of grafts, 
total operative time, adrenaline and IABP 
insertion in the low EF group. The mean number 
of grafts was 3.12 ± 1.00; the mean 
cardiopulmonary bypass time (min) was 111.95 ± 
41.27, the mean aortic cross-clamp time (min) was 
66.72 ± 24.90 and the mean total operative time 
(hours) was 5.53 ± 0.81. In the literature, the mean 
number of grafts was 3.5 ±1.1, the mean 
cardiopulmonary bypass time (min) was 88 ± 28.1; 
the mean myocardial ischemic time (min) was 
40.3 ± 19 [5]. Other study reported that the mean 
cardiopulmonary bypass time (min) was 87.8 ± 
47.3; the mean myocardial ischemic time (min) 
was 56.2 ± 31.1 [8]. The difference in the results 
could be attributed to different patients’ 
characteristics between the reported studies. 
The mean drainage was 749.35 ± 377.99 ml 
which is similar to other series [11]. The amount 
of the postoperative blood loss can differ 
significantly between studies due to several 
factors related to the patients, surgical technique 
and surgeons. Mechanical ventilation, ICU and 
hospital were significantly longer in low EF 
patients which is consistent with what is reported 
in the literature [12]. Low EF is associated with 
hemodynamic instability, the increased use of 
IABP and inotropes and these factors affect the 
duration of mechanical, ICU and hospital stay 
directly. Postoperative complications were 
independently related to low EF including 
infectious and neurological complications [8, 12].  
Preoperative EF of the targeted study group 
improved in the immediate postoperative period, 
and of the improvement continued at the three 
months follow-up. CABG in low EF patients had 
superior results compared to medical therapy. The 
Coronary Artery Surgery Study (CASS) study 
demonstrated that only 38% of medically treated 
patients (EF 35%) were alive and free of moderate 
or severe limitations five years after the 
treatment. Surgical approaches to CAD patients 
with low EF include CABG, ventricular 
remodeling, and cardiac transplantation [13]. 
Alderman and associates showed that patients 
with an EF<35% treated with medical therapy had 
a 43% 5-year survival rate compared with a 63% 
5-year survival in the surgically treated patients 
[14]. A study followed a group of CABG patients 
with an EF 50% for seven years and showed that 
84% of the surgically treated patients were alive 
at seven years, whereas only 70% of medically 
treated patients were alive [15]. 
The current recommendation is using 
dobutamine stress echocardiography to assess 
myocardial viability to select patients in whom 
recovery of LV function would outweigh the risk of 
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surgical revascularization [16]. Stress 
echocardiography was used preoperatively in the 
study population. We believe that several factors 
may have contributed to our good operative and 
short-term results such as good control of 
diabetes, use of internal mammary artery grafting 
and reasonable intraoperative and postoperative 
use of inotropic support and IABP. Additionally, 
complete myocardial revascularization and 
successful myocardial protection are important 
clues and predictors of favorable short- and long-
term results after CABG in patients with poor LV 
function. The results of this study show that CABG 
in low EF is associated with more complications 
compared with normal EF patients; however, it 
improves the clinical and echocardiographic 
outcomes. 
Study limitations: 
This series represents a prospective non-
randomized study. Patients were selected 
exclusively for CABG procedure and according to 
the presence of an adequate amount of viable 
myocardium. Therefore, they were not randomly 
assigned to a different type of therapeutic 
management. Changes in operative strategies 
along the study course occurred and, thus, may 
have influenced the postoperative results and 
related data interpretation. The small sample size 
was one of the limitations; the high surgical risk 
was a considerable reason that made several 
patients defer surgery. 
Conclusion 
In patients with low ejection fraction and 
viable myocardium, CABG improves the EF and 
heart failure symptoms; despite the higher 
postoperative complications. Identification of 
independent mortality predictors aid in risk 
stratification and patients’ optimization by 
improving the modifiable risk factors. 
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